Yves Renaudineau
Renaudineau, Yves, 1969-....
VIAF ID: 198794149 (Personal)
Permalink: http://viaf.org/viaf/198794149
Preferred Forms
- 100 1 _ ‡a Renaudineau, Yves ‡d 1969-...
- 100 1 _ ‡a Renaudineau, Yves, ‡d 1969-....
- 100 0 _ ‡a Yves Renaudineau
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
B lymphocytes apoptosis resistance in chronic lymphocytic leukemia : implication of a neurotrophin, BDNF, the neurotensin receptor NTSR2, and Nurse-Like Cells. | |
Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica | |
Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration | |
Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome | |
Diagnostic and pathogenic implications of the heterogeneity of antiendothelial cell antibodies. | |
The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review | |
DNA methylation and B-cell autoreactivity | |
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1 | |
Effects of anti-endothelial cell antibodies in leprosy and malaria | |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study | |
Endothelium, a target for immune-mediated assault in connective tissue disease | |
Epigenetics in leukemia | |
Epigénétique dans les leucémies. | |
Etude de la signalisation calcique du lymphocyte B en pathologie | |
Étude des effets de l'alpha-énolase sur les cellules mononucléées du sang périphérique de sujets sains et de patients atteints de polyarthrite rhumatoïde, et dans le modèle murin d'arthrite induite au collagène | |
The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome | |
Follicular helper T cells involvement in the physiopathogenesis of chronic lymphocytic leukemia. | |
Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis | |
How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses | |
Human endogenous retrovirus group E and its involvement in diseases | |
Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy. | |
IgG subclasses of human autoantibodies | |
Immunophenotyping As a New Tool for Classification and Monitoring of Systemic Autoimmune Diseases | |
Implication des lymphocytes B et de BAFF dans l'apoptose des cellules épithéliales des glandes salivaires au cours du syndrome de Gougerot-Sjögren | |
Importance of IgG glycosylation in rheumatoid arthritis. | |
Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20) | |
In seroconverted rheumatoid arthritis patients a multi-reactive anti-herpes IgM profile is associated with disease activity | |
Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade | |
[Influence of epigenetic in Sjögren's syndrome]. | |
The Innate Part of the Adaptive Immune System | |
Interest of the CD5 | |
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity | |
Isolated Cardiac Richter Syndrome: a Case Report | |
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes | |
Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up. | |
Maladies auto-immunes et marqueurs sérologiques : l’exemple des anticorps anti-phospholipides et des chaînes légères libres | |
Mécanismes épigénétiques et influence du micro-environnement tumoral | |
Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis | |
Methylome alterations during Sjögren’s syndrome. | |
MicroRNAs and multiple sclerosis: from physiopathology toward therapy | |
Molecular Dynamics Simulations of Membrane-Bound STIM1 to Investigate Conformational Changes during STIM1 Activation upon Calcium Release. | |
Monoclonal anti-CD20 antibodies: mechanisms of action and monitoring of biological effects | |
The new B-cell-specific exon 1B of the CD5 mRNA favors autoimmunity by preventing the membrane expression of CD5. | |
New ELISA for B cell-activating factor | |
News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination | |
No. | |
Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion | |
Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo BMT | |
The paradox of CD5-expressing B cells in systemic lupus erythematosus | |
Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases | |
Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei | |
Pierre Youinou: when intuition and determination meet autoimmunity. | |
Prevalence of antibodies to hepatitis C among recently treated leprosy patients in Senegal parallels those in normal populations | |
Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells | |
Rapid and complete response to idelalisib in a case of Richter syndrome | |
Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases | |
Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab). | |
Re-emergence of yellow fever in Senegal in 1995. | |
Ré-évaluation de l'apport de l'immunofluorescence directe (recherche de lupus band test) seul et combiné dans le diagnostic du lupus et de sa forme systémique | |
Recent progress in the understanding of B-cell functions in autoimmunity | |
Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation | |
Régulation du gène CD5 dans les lymphocytes B humains | |
The regulatory capacity of B cells directs the aggressiveness of CLL | |
Renal involvement in Wegener's granulomatosis. | |
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy | |
The revolution of epigenetics in the field of autoimmunity | |
Rheumatoid factor on a daily basis | |
Rôle des lymphocytes T CD4+ folliculaires dans la physiopathologie de la leucémie lymphoïde chronique | |
Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells | |
Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren's syndrome | |
Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden | |
Soluble Fcgamma receptor IIIb alters the function of polymorphonuclear neutrophils but extends their survival | |
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia | |
Study of calcium entries deregulation in chronic lymphocytic leukemia B-cells : evidence for a new therapeutic target. | |
Toll-Like Receptors, Infections, and Rheumatoid Arthritis | |
Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysis. | |
Virus de l'hépatite C : faible prévalence et sérotype 2 en Afrique de l'Ouest (étude menée à l'Institut Pasteur de Dakar en 1995) |